Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physicians Health Study: Beta-Carotene and AMD
NCT00000152Phase 3Unknown
- Sponsor
- National Eye Institute
- Start
- Apr 1982
- Modality
- Metabolically Activated Prodrugs
01
Overview
Phase 3, randomised, double-blind trial of beta-carotene in age-related macular degeneration (AMD) (4 arms), sponsored by National Eye Institute. Primary endpoint: Incidence of reported Age-Related Macular Degeneration at 12 years. Status: unknown.
02
Drugs
beta-carotene
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT00000152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000152.